Xiji Biotechnology
Xiji Bio focuses on the cell and gene therapy (CGT) field, providing CDMO services covering plasmids, viral vectors, and cell products
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Xiji Bio focuses on the cell and gene therapy (CGT) field, providing CDMO services covering plasmids, viral vectors, and cell products
Xiji Biotechnology's investors include Shennong Capital, Shunxi Fund, Zhixuan Wealth.
Xiji Biotechnology most recently raised Series A in February 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 9, 2026 | Series A | Shennong Capital, Shunxi Fund, Zhixuan Wealth |